Signatory Authority

SOP Title: 100: REB Administration
Number. Version: REB SOP 103 Signatory Authority
Version Date: July 27, 2011
Approval Date: July 27, 2011
Approved By: REB
Revised and Approved: April 20, 2016

1.0 Purpose

This SOP describes signature authority for REB actions.

2.0 General Policy Statement

The REB Chair, Vice Chair or designate is authorized to sign any and all documents in
connection with the review and approval of research projects involving the use of humans as
participants which have been reviewed and approved pursuant to REB policies and procedures
and upon decision of the REB.

3.0 Specific Procedures

3.1 Authorization for Signatory Authority

The REB Chair and Vice-Chair have authorization to sign documents not described in this policy.

3.2 Results of Reviews, Actions and Decisions

The results of reviews and actions taken by the REB, either by the full Board, sub-committee, or
expedited review, that grant Principal Investigators initial or continuing approval of research
projects involving human participants may be signed by the REB Chair, REB Vice-Chair or
his/her assigned designate. If a designate has been assigned, a meeting will be convened as soon
as possible to confer in any decision(s) made.

3.3 Correspondence Providing Approval or Rejection of Study Submission

The REBs approval or rejection of an application for study approval must be communicated to
the Principal Investigator by correspondence from the REB.

3.4 Communication during Consideration of the Study Submission

Correspondence and communication between the REB and the Principal Investigator is
coordinated through Research Ethics Board Administration.

3.5 Correspondence Providing Approval of Post-Approval Activities

REB approval of amendments and continuing review, etc. will be issued by Research Ethics
Board Administration upon the requisite approval from the Chair or Vice-Chair having been
noted in the correspondence related to the study